Sherlock Biosciences Expects Sense Biodetection Buy to Accelerate Commercialization Plans

The firm now anticipates accelerating its commercialization phase by one to two years and will mix and match its technologies going forward.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Northpond ,Massachusetts ,United States ,California ,Watertown ,Poland ,John Bishop ,Brian Dechairo ,David Wall ,Harry Lamble ,Mike Ruben ,Santa Barbara ,Sherlock Biosciences ,Heiner Dreismann ,Johns Hopkins ,University Of California ,Innova Medical Group ,Lucira Health ,Cue Health ,Tulane University ,Melinda Gates Foundation ,Skoch Group ,Sense Biodetection ,Bsense Bio ,United Kingdom Based ,Open Philanthropy ,Emergency Use ,Deborah Hung ,Koch Disruptive Technologies ,Roche Molecular Systems Heiner Dreismann ,Illumina Ventures ,Northpond Ventures ,Talis Biomedical ,Aptitude Medical ,Visby Medical ,Domus Diagnostics ,Midge Medical ,Innova Medical ,